Diamyd Medical highlights Type 1 Diabetes prevention, Phase 3
21 Apr 2025 //
PR NEWSWIRE
Diamyd Medical Pursues Accelerated Approval For T1D Precision Medicine
09 Sep 2024 //
PR NEWSWIRE
Diamyd® Phase 3 Trial Recruitment Milestone
12 Apr 2024 //
PR NEWSWIRE
Promising topline results for intralymphatic Diamyd® in patients with LADA
07 Jul 2022 //
PRNEWSWIRE